Breaking News

Monday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
RDHL

RedHill Biopharma

$8.76

0.21 (2.46%)

08:20
09/18/17
09/18
08:20
09/18/17
08:20
Hot Stocks
RedHill Biopharma receives Notice of Allowance from USPTO for YELIVA, MESUPRON »

RedHill Biopharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

Over a week ago
RDHL

RedHill Biopharma

$8.42

0.0499 (0.60%)

, CXRX

Concordia

$1.31

-0.01 (-0.76%)

07:13
09/13/17
09/13
07:13
09/13/17
07:13
Hot Stocks
RedHill Biopharma initiates promotion of Esomeprazole Strontium in the U.S. »

RedHill Biopharma (RDHL)…

RDHL

RedHill Biopharma

$8.42

0.0499 (0.60%)

CXRX

Concordia

$1.31

-0.01 (-0.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

Over a month ago
RDHL

RedHill Biopharma

, CXRX

Concordia

$1.25

-0.03 (-2.34%)

07:12
08/17/17
08/17
07:12
08/17/17
07:12
Hot Stocks
RedHill announces commercialization agreement for Esomeprazole Strontium »

RedHill Biopharma (RDHL)…

RDHL

RedHill Biopharma

CXRX

Concordia

$1.25

-0.03 (-2.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RDHL

RedHill Biopharma

07:08
08/17/17
08/17
07:08
08/17/17
07:08
Hot Stocks
RedHill announces commercialization agreement for Esomeprazole Strontium »

RedHill Biopharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RDHL

RedHill Biopharma

$8.81

0.28 (3.28%)

08:14
07/17/17
07/17
08:14
07/17/17
08:14
Hot Stocks
RedHill Biopharma announces last patient visit in BEKINDA Phase II study »

RedHill Biopharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RDHL

RedHill Biopharma

$8.18

-0.03 (-0.37%)

08:12
07/12/17
07/12
08:12
07/12/17
08:12
Hot Stocks
RedHill Biopharma expects DSMB meeting on RHB-104 in late July »

RedHill Biopharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a quarter ago
RDHL

RedHill Biopharma

$9.34

0.22 (2.41%)

07:55
06/21/17
06/21
07:55
06/21/17
07:55
Conference/Events
RedHill Biopharma to hold a conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

RDHL

RedHill Biopharma

$9.35

0.27 (2.97%)

04:55
06/21/17
06/21
04:55
06/21/17
04:55
Conference/Events
RedHill Biopharma to hold a conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

RDHL

RedHill Biopharma

$9.08

0.48 (5.58%)

15:00
06/20/17
06/20
15:00
06/20/17
15:00
Conference/Events
RedHill Biopharma to hold a conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

RDHL

RedHill Biopharma

$9.32

-0.15 (-1.58%)

08:16
06/15/17
06/15
08:16
06/15/17
08:16
Hot Stocks
RedHill Biopharma initiates confirmatory Phase III study with RHB-105 »

RedHill Biopharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.